Non-invasive airway health assessment: Synchrotron imaging reveals effects of rehydrating treatments on mucociliary transit in-vivo
Open Access
- 14 January 2014
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 4 (1) , 3689
Abstract
To determine the efficacy of potential cystic fibrosis (CF) therapies we have developed a novel mucociliary transit (MCT) measurement that uses synchrotron phase contrast X-ray imaging (PCXI) to non-invasively measure the transit rate of individual micron-sized particles deposited into the airways of live mice. The aim of this study was to image changes in MCT produced by a rehydrating treatment based on hypertonic saline (HS), a current CF clinical treatment. Live mice received HS containing a long acting epithelial sodium channel blocker (P308); isotonic saline; or no treatment, using a nebuliser integrated within a small-animal ventilator circuit. Marker particle motion was tracked for 20 minutes using PCXI. There were statistically significant increases in MCT in the isotonic and HS-P308 groups. The ability to quantify in vivo changes in MCT may have utility in pre-clinical research studies designed to bring new genetic and pharmaceutical treatments for respiratory diseases into clinical trials.Keywords
This publication has 28 references indexed in Scilit:
- Respiratory Consequences of Mild-to-Moderate Obesity: Impact on Exercise Performance in Health and in Chronic Obstructive Pulmonary DiseasePulmonary Medicine, 2012
- Synchrotron phase-contrast X-ray imaging reveals fluid dosing dynamics for gene transfer into mouse airwaysGene Therapy, 2011
- Noninvasive real-time measurement of nasal mucociliary clearance in mice by pinhole gamma scintigraphyJournal of Applied Physiology, 2010
- Single‐dose lentiviral gene transfer for lifetime airway gene expressionThe Journal of Gene Medicine, 2009
- Real-time non-invasive detection of inhalable particulates delivered into live mouse airwaysJournal of Synchrotron Radiation, 2009
- Pharmacological Properties of N-(3,5-Diamino-6-chloropyrazine-2-carbonyl)-N′-4-[4-(2,3-dihydroxypropoxy)phenyl]butyl-guanidine Methanesulfonate (552-02), a Novel Epithelial Sodium Channel Blocker with Potential Clinical Efficacy for Cystic Fibrosis Lung DiseaseThe Journal of Pharmacology and Experimental Therapeutics, 2008
- Soluble Mediators, Not Cilia, Determine Airway Surface Liquid Volume in Normal and Cystic Fibrosis Superficial Airway EpitheliaJournal of General Physiology, 2006
- Mucociliary transport determined by in vivo microdialysis in the airways of normal and CF miceAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2004
- Phase objects in synchrotron radiation hard x-ray imagingJournal of Physics D: Applied Physics, 1996
- On the possibilities of x-ray phase contrast microimaging by coherent high-energy synchrotron radiationReview of Scientific Instruments, 1995